The quantitative pathology imaging market size is poised for an extraordinary surge, with estimations predicting a valuation of US$ 9.5 Billion by 2032, a significant upsurge from US$ 2.77 Billion recorded in 2022. This meteoric rise is anticipated to occur through a robust Compound Annual Growth Rate (CAGR) of 11.9% during the forecast period.
The progressive advancements in quantitative pathology imaging technologies are driving this exponential market expansion. These technologies are pivotal in revolutionizing the field of pathology, offering precise and detailed insights that significantly enhance diagnostic accuracy and treatment decisions.
Get Sample Copy of Latest Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-5041
Digital pathology is another important driver of the QPI market. Digital pathology involves the use of digital scanners to convert tissue samples into digital images. These images can then be analyzed using QPI software to extract quantitative information. Digital pathology is becoming increasingly popular, as it offers a number of advantages over traditional microscopy, such as improved image quality, easier sharing of images, and the ability to perform quantitative analysis.
The growing demand for personalized medicine is also driving the QPI market. Personalized medicine involves tailoring treatment to the individual patient based on their unique genetic and molecular characteristics. QPI can be used to identify biomarkers that can be used to guide personalized treatment decisions.
The key takeaways from the quantitative pathology imaging market report are as follows:
- The global quantitative pathology imaging market is expected to grow at a CAGR of 11.9% during the forecast period.
- The market is driven by the increasing prevalence of cancer and other chronic diseases, the rising demand for personalized medicine, and the growing adoption of digital pathology.
- Oncology is the largest segment of the quantitative pathology imaging market, accounting for over 50% of the market share in 2022.
- North America is the largest regional market for quantitative pathology imaging, accounting for over 40% of the global market share in 2022.
Discover The Power Of Methodology-Driven Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5041
Key Companies Profiled:
- Leica Biosystems (Danaher)
- Hamamatsu Photonics, Inc.
- Koninklijke Philips N.V.
- Olympus Corporation
- F. Hoffmann-La Roche Ltd.
- Mikroscan Technologies
- Inspirata, Inc.
- 3DHISTECH Ltd.
- Visiopharm A/S
- Huron Technologies International, Inc.
- ContextVision AB
Key Segments In The Quantitative Pathology Imaging Market:
By Product:
- Instruments
- Software
- Services
By Application:
- Drug Discovery and Development
- Academic Research
- Disease Diagnosis
By End-User:
- Hospitals
- Clinics
- Pathology Diagnostic Laboratories
- Research Institutes
By Region:
- North America
- Latin America
- Europe
- Asia
- Middle East and Africa
Unlock Exclusive Market Segments Insights: Buy Now: https://www.futuremarketinsights.com/checkout/5041
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
